Date: 20-Aug-2019

Sun Pharma to develop more generic products in China

Indian pharma major Sun Pharmaceutical Industries Ltd. has announced that one of its wholly owned subsidiaries has granted an exclusive license to a subsidiary of China Medical System Holdings Ltd. (CMS) to develop and commercialize seven generic products in Mainland China.